Wall Street Experts
ver. ZuMIgo(08/25)
Bliss GVS Pharma Limited
Rachunek Zysków i Strat
Przychody TTM (mln): 8 002
EBIT TTM (mln): 1 099
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
Rok finansowy |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2025 |
Przychód (mln) |
43 |
623 |
1,024 |
1,330 |
1,689 |
2,188 |
2,667 |
3,966 |
3,469 |
4,071 |
5,469 |
7,997 |
3,638 |
8,861 |
6,819 |
5,687 |
7,379 |
7,516 |
7,702 |
8,097 |
Przychód Δ r/r |
0.0% |
1364.2% |
64.3% |
29.8% |
27.0% |
29.6% |
21.9% |
48.7% |
-12.5% |
17.4% |
34.3% |
46.2% |
-54.5% |
143.6% |
-23.0% |
-16.6% |
29.8% |
1.9% |
2.5% |
5.1% |
Marża brutto |
59.3% |
42.8% |
56.4% |
47.5% |
46.4% |
41.8% |
40.9% |
48.6% |
50.8% |
56.4% |
53.1% |
55.1% |
46.6% |
30.9% |
35.5% |
42.2% |
47.0% |
46.6% |
34.6% |
48.9% |
EBIT (mln) |
6 |
65 |
366 |
425 |
478 |
551 |
834 |
1,046 |
628 |
1,114 |
1,733 |
1,916 |
1,065 |
1,511 |
1,111 |
894 |
1,013 |
986 |
1,242 |
2,840 |
EBIT Δ r/r |
0.0% |
994.2% |
460.7% |
16.1% |
12.4% |
15.3% |
51.4% |
25.3% |
-40.0% |
77.5% |
55.5% |
10.6% |
-44.4% |
41.9% |
-26.4% |
-19.5% |
13.3% |
-2.6% |
25.9% |
128.6% |
EBIT (%) |
14.0% |
10.5% |
35.8% |
32.0% |
28.3% |
25.2% |
31.3% |
26.4% |
18.1% |
27.4% |
31.7% |
24.0% |
29.3% |
17.0% |
16.3% |
15.7% |
13.7% |
13.1% |
16.1% |
35.1% |
Koszty finansowe (mln) |
0 |
7 |
14 |
23 |
20 |
21 |
40 |
0 |
0 |
154 |
157 |
124 |
82 |
41 |
48 |
43 |
29 |
104 |
69 |
81 |
EBITDA (mln) |
8 |
94 |
395 |
461 |
532 |
606 |
871 |
1,107 |
740 |
1,237 |
1,875 |
2,121 |
1,279 |
2,059 |
1,620 |
1,272 |
1,650 |
1,351 |
1,506 |
1,267 |
EBITDA(%) |
18.5% |
15.2% |
38.6% |
34.7% |
31.5% |
27.7% |
32.7% |
27.9% |
21.3% |
30.4% |
34.3% |
26.5% |
35.1% |
23.2% |
23.8% |
22.4% |
22.4% |
18.0% |
19.6% |
15.6% |
Podatek (mln) |
3 |
20 |
15 |
28 |
40 |
124 |
269 |
499 |
295 |
346 |
480 |
628 |
323 |
553 |
337 |
302 |
310 |
292 |
353 |
354 |
Zysk Netto (mln) |
4 |
38 |
337 |
375 |
417 |
406 |
525 |
577 |
410 |
599 |
825 |
856 |
588 |
1,237 |
973 |
685 |
150 |
709 |
755 |
843 |
Zysk netto Δ r/r |
0.0% |
806.5% |
778.3% |
11.0% |
11.4% |
-2.6% |
29.3% |
9.9% |
-29.0% |
46.2% |
37.7% |
3.8% |
-31.3% |
110.5% |
-21.4% |
-29.6% |
-78.0% |
371.1% |
6.5% |
11.7% |
Zysk netto (%) |
10.0% |
6.2% |
32.9% |
28.2% |
24.7% |
18.6% |
19.7% |
14.6% |
11.8% |
14.7% |
15.1% |
10.7% |
16.2% |
14.0% |
14.3% |
12.0% |
2.0% |
9.4% |
9.8% |
10.4% |
EPS |
0.0728 |
6.53 |
2.04 |
3.63 |
4.04 |
3.94 |
5.09 |
5.6 |
3.97 |
5.81 |
8.0 |
7.95 |
5.7 |
11.99 |
9.43 |
6.64 |
1.46 |
6.83 |
7.23 |
8.02 |
EPS (rozwodnione) |
0.0728 |
6.53 |
2.04 |
3.63 |
4.04 |
3.94 |
5.09 |
5.6 |
3.97 |
5.81 |
8.0 |
7.95 |
5.7 |
11.99 |
9.43 |
6.49 |
1.43 |
6.72 |
7.11 |
7.95 |
Ilośc akcji (mln) |
58 |
6 |
165 |
103 |
103 |
103 |
103 |
103 |
103 |
103 |
103 |
103 |
103 |
103 |
103 |
103 |
103 |
104 |
104 |
106 |
Ważona ilośc akcji (mln) |
58 |
6 |
165 |
103 |
103 |
103 |
103 |
103 |
103 |
103 |
103 |
103 |
103 |
103 |
103 |
105 |
105 |
105 |
106 |
106 |
Waluta |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |